| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the Management of von Willebrand Disease and Hemophilia
|
Rizzo, Toni
|
|
2013
|
13 |
13 |
p. 18-21
|
artikel
|
| 2 |
Anticoagulant Treatment Requires Special Care in the Elderly
|
Buckley, Rita
|
|
2013
|
13 |
13 |
p. 30-30
|
artikel
|
| 3 |
Anticoagulation for Isolated Distal Deep Vein Thrombosis May Reduce Serious Complications
|
Vinall, Maria
|
|
2013
|
13 |
13 |
p. 10-11
|
artikel
|
| 4 |
Apixaban is an Effective Replacement for Conventional Anticoagulation Therapy
|
Vinall, Maria
|
|
2013
|
13 |
13 |
p. 11-12
|
artikel
|
| 5 |
Changing Paradigms regarding New Antiplatelet Therapy
|
Vinall, Maria
|
|
2013
|
13 |
13 |
p. 24-25
|
artikel
|
| 6 |
Complement Inactive in E. coli Shiga Toxin-Producing Diseases
|
Buckley, Rita
|
|
2013
|
13 |
13 |
p. 16-17
|
artikel
|
| 7 |
Data from New Oral Anticoagulants Provide Clues for Future Drug Development
|
Nichols, Emma Hitt
|
|
2013
|
13 |
13 |
p. 4-5
|
artikel
|
| 8 |
Hemostatic Disorders in Women
|
Rizzo, Toni
|
|
2013
|
13 |
13 |
p. 26-27
|
artikel
|
| 9 |
In Search of the Holy Grail of Anticoagulant Therapy
|
Kuznar, Wayne
|
|
2013
|
13 |
13 |
p. 12-13
|
artikel
|
| 10 |
Investigational Small Molecule Rapidly Reverses Effects of New Oral Anticoagulants, Heparins
|
Kuznar, Wayne
|
|
2013
|
13 |
13 |
p. 14-15
|
artikel
|
| 11 |
Mendelian Randomization as a Promising Approach to Define Which Biomarkers are Causal for Myocardial Infarction
|
Nichols, Emma Hitt
|
|
2013
|
13 |
13 |
p. 6-8
|
artikel
|
| 12 |
Phenotyping and Genotyping of Platelet Disorders
|
Buckley, Rita
|
|
2013
|
13 |
13 |
p. 29-30
|
artikel
|
| 13 |
Protein Bioengineering Strategies Improve upon Hemophilia Treatments
|
Kuznar, Wayne
|
|
2013
|
13 |
13 |
p. 15-16
|
artikel
|
| 14 |
Recurrent Venous Thrombosis
|
Vinall, Maria
|
|
2013
|
13 |
13 |
p. 22-23
|
artikel
|
| 15 |
TAFI(a) Assays Measure Extent of Activation in Patient Populations
|
Buckley, Rita
|
|
2013
|
13 |
13 |
p. 28-29
|
artikel
|
| 16 |
Use of Dalteparin beyond 6 Months in Cancer Patients with VTE is Feasible
|
Vinall, Maria
|
|
2013
|
13 |
13 |
p. 13-14
|
artikel
|
Tijdschrift beschrijving